New AI tool ‘DeepHeme’ improves blood cancer diagnosis
A new artificial intelligence (AI)-powered diagnostic tool, DeepHeme, is able to perform individual cell classifications with an accuracy comparable to human experts, according
News
Cellular Therapy
Lymphoma
Aggressive B-Cell Lymphomas
Multiple Myeloma
News
Can radiation prime the immune system to fight blood cancer?
In 1953, a physician named RH Mole published a paper in the British Journal of Radiology describing a surprising phenomenon he called the
Multiple Myeloma
News
FDA extends review for DREAMM-7, DREAMM-8 therapy in myeloma
The US Food and Drug Administration (FDA) extended the review timeline for the Biologics License Application for the belantamab mafodotin combinations investigated in
SOHO 2025
Meeting News
Myelodysplastic Syndromes
News
SOHO Insider Podcast
SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025
Saad Usmani, MD, chief of the myeloma service at Memorial Sloan Kettering Cancer Center, and Phillip Scheinberg, MD, president of the Society of
EHA 2025
Meetings / Conferences
News
Phase 1 subcutaneous blinatumomab safe, effective in R/R B-ALL
Elias Jabbour, MD, leukemia professor in the University of Texas MD Anderson Cancer Center, discusses the phase 1/2 expansion study of subcutaneous blinatumomab
EHA 2025
Myeloproliferative Neoplasms
Video Interviews
Novel therapy INCA in ET shows positive results in early-phase data
Lucia Masarova, MD, an assistant professor in the Department of Leukemia at the University of Texas MD Anderson, discusses the 2025 EHA late-breaking
Multiple Myeloma
News
FDA panel rejects blenrep combo in myeloma over safety, dosing concerns
The combinations, bortezomib and dexamethasone and pomalidomide and dexamethasone, were evaluated in adults with R/R multiple myeloma who have received at least one
SOHO 2025
News
Video Interviews
Society Updates
We are in full countdown mode to SOHO 2025
Register at soho.click/2025.
EHA 2025
News
Heme professionals report high burnout in EHA member survey
Long hours, lack of support, and poor management were identified as contributors to burnout among hematology professionals, according to a survey presented at